0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5927

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2016;315(5):456. doi:10.1001/jama.2015.18965.

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Ronen Zalts, MD; Dana Ben-Hur, MD; Ali Yahia, MD; et al.
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.7705

JAMA Internal Medicine | 
Viewpoint |  FREE ONLINE FIRST
Amy Kapczynski, JD
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.8155

JAMA Neurology | 
Original Investigation |  FREE ONLINE FIRST
Helena M. van der Holst, MD; Ingeborg W. M. van Uden, MD; Anil M. Tuladhar, MD; et al.
JAMA Neurol. Published online February 01, 2016. doi:10.1001/jamaneurol.2015.4560
Includes: Supplemental Content

JAMA Internal Medicine | 
Editorial | 
Adam Jacob Schoenfeld, MD; Deborah Grady, MD, MPH
JAMA Intern Med. 2016;176(2):172-174. doi:10.1001/jamainternmed.2015.7927.

JAMA Internal Medicine | 
Invited Commentary | 
Carl J. Lavie, MD; Parham Parto, MD; Edward Archer, PhD
JAMA Intern Med. 2016;176(2):217-218. doi:10.1001/jamainternmed.2015.7571.

JAMA Internal Medicine | 
Original Investigation | 
Casey Crump, MD, PhD; Jan Sundquist, MD, PhD; Marilyn A. Winkleby, PhD; et al.
JAMA Intern Med. 2016;176(2):210-216. doi:10.1001/jamainternmed.2015.7444.
Includes: Supplemental Content

JAMA Internal Medicine | 
Original Investigation | 
Ajay Dharod, MD; Elsayed Z. Soliman, MD, MSc, MS; Farah Dawood, MD; et al.
JAMA Intern Med. 2016;176(2):219-227. doi:10.1001/jamainternmed.2015.7655.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA
News From the Food and Drug Administration  | 
Helping Kids Combat Arrhythmia
Rebecca Voelker, MSJ
JAMA Internal Medicine
Evidence to Practice  | 
Sacubitril-Valsartan for the Treatment of Heart Failure Effectiveness and Value
Daniel A. Ollendorf, PhD; Alexander T. Sandhu, MD; Steven D. Pearson, MD, MSc